Examination of Clinical usefulness of FES-PET for hormone therapy against recurrence after adjuvant hormone therapy of estrogen receptor-positive breast cancer
Not Applicable
- Conditions
- Recurrence of estrogen-positive breast cancer
- Registration Number
- JPRN-UMIN000016488
- Lead Sponsor
- Institusion of Biomedical Resarch and Innovation
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Female
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
Subject who can not be maintained for 60 minutes on her back Subject who is claustrophobic extremely Subject with poor blood sugar control ( blood glucose kevel is more then 200mg/dl on the examination day)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method